LipoPIC GLP-1 se une al amplio abanico de productos de Arkopharma para el mantenimiento del peso corporal con unos resultados clnicos que nos permiten cubrir las necesidades de diferentes tipos de pacientes y es el primer preparado farmacutico que acta directamente sobre GLP-1 , asegura Luca San Miguel , directora de asuntos regulatorios y mdicos de Arkopharma
These data support a normal role for insulin signaling, as a determinant of chondrocyte size, which is apparently cannot compensated by local upregulation of IGF-1/IGF-1R
The Journal of Nutritional Biochemistry, 17 , 7388
doi: 10.1016/j.bbi.2022.06.016 46 QinLWuXBlockMLLiuYBreeseGRHongJ-Set al
The common adverse reactions of GLP-1R agonists include gastrointestinal reactions, mainly loss of appetite, nausea, vomiting, diarrhea, abdominal pain, etc., primarily mild or moderate